UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study

The lancet oncology, 2019-04, Vol.20 (4), p.518-530

2019

Volltextzugriff (PDF)

Clinical and biomarker predictors of side effects from tamoxifen

Breast cancer research and treatment, 2012-04, Vol.132 (3), p.1107-1118

2012

Volltextzugriff (PDF)

Communication of BRCA Results and Family Testing in 1,103 High-Risk Women

Cancer epidemiology, biomarkers & prevention, 2010-09, Vol.19 (9), p.2211-2219

2010

Volltextzugriff (PDF)

Comparison of Methods to Measure Low Serum Estradiol Levels in Postmenopausal Women

The journal of clinical endocrinology and metabolism, 2006-10, Vol.91 (10), p.3791-3797

2006

Volltextzugriff (PDF)

Eligibility criteria in private and public coverage policies for BRCA genetic testing and genetic counseling

Genetics in medicine, 2011-12, Vol.13 (12), p.1045-1050

2011

Volltextzugriff (PDF)

Pharmacogenetic testing affects choice of therapy among women considering tamoxifen treatment

Genome medicine, 2011-10, Vol.3 (10), p.64-64

2011

Volltextzugriff (PDF)

Family Communication of BRCA1/2 Results and Family Uptake of BRCA1/2 Testing in a Diverse Population of BRCA1/2 Carriers

Journal of genetic counseling, 2013-10, Vol.22 (5), p.603-612

2013

Volltextzugriff (PDF)

Association of statin use and development and progression of hip osteoarthritis in elderly women

Journal of rheumatology, 2005-01, Vol.32 (1), p.106

2005

Volltextzugriff (PDF)

Classifying Variants of Undetermined Significance in BRCA2 with Protein Likelihood Ratios

Cancer informatics, 2008-01, Vol.2008 (1), p.203-216

2008

Volltextzugriff (PDF)

Fecal Incontinence in Females Older Than Aged 40 Years: Who is at Risk?

Diseases of the colon & rectum, 2006-06, Vol.49 (6), p.841-851

2006

Volltextzugriff (PDF)

Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers

Genetic testing and molecular biomarkers, 2009-02, Vol.13 (1), p.51-56

2009

Volltextzugriff (PDF)

Pre-counseling Education for Low Literacy Women at Risk of Hereditary Breast and Ovarian Cancer (HBOC): Patient Experiences Using the Cancer Risk Education Intervention Tool (CREdIT)

Journal of genetic counseling, 2010-10, Vol.19 (5), p.447-462

2010

Volltextzugriff (PDF)

Characteristics and temporal trends in patient registries: focus on the life sciences industry, 1981-2012

Pharmacoepidemiology and drug safety, 2015-04, Vol.24 (4), p.389-398

2015

Volltextzugriff (PDF)

Prevalence and characteristics of pancreatic cancer in families with BRCA1 and BRCA2 mutations

Familial cancer, 2009-06, Vol.8 (2), p.153-158

2009

Volltextzugriff (PDF)

Endogenous Sex Hormones, Breast Cancer Risk, and Tamoxifen Response: An Ancillary Study in the NSABP Breast Cancer Prevention Trial (P-1)

JNCI : Journal of the National Cancer Institute, 2006-01, Vol.98 (2), p.110-115

2006

Volltextzugriff (PDF)

Genetic counseling, cancer screening, breast cancer characteristics, and general health among a diverse population of BRCA genetic testers

Journal of health care for the poor and underserved, 2013-08, Vol.24 (3), p.1150-1166

2013

Volltextzugriff (PDF)

NatHER: protocol for systematic evaluation of trends in survival among patients with HER2-positive advanced breast cancer

Systematic reviews, 2015-10, Vol.4 (1), p.133-133, Article 133

2015

Volltextzugriff (PDF)

Update in Women’s Health

Journal of general internal medicine : JGIM, 2010-04, Vol.25 (4), p.363-368

2010

Volltextzugriff (PDF)

Differences in US healthcare coverage policies in BRCA testing and potential implications

Personalized medicine, 2012-01, Vol.9 (1), p.5-8

2012

Volltextzugriff (PDF)

C-reactive protein and ischemia in users and nonusers of β-blockers and statins: Data from the Heart and Soul Study

Circulation (New York, N.Y.), 2003-01, Vol.107 (2), p.245-250

2003

Volltextzugriff (PDF)

Pertuzumab and trastuzumab for HER2-amplified metastatic colorectal cancer: an updated report from MyPathway, a multicentre, open-label, phase 2a multiple basket study

The lancet oncology, 2019-03, Vol.20 (4), p.518-530

2019

Volltextzugriff (PDF)

Coronary Heart Disease in Women: Hormone Replacement Therapy

Current treatment options in cardiovascular medicine, 2002-04, Vol.4 (2), p.129-136

2002

Volltextzugriff (PDF)

Abstract C067: Evaluation of data from a new mobile HPV vaccination program in South Carolina, U.S

Cancer epidemiology, biomarkers & prevention, 2023-12, Vol.32 (12_Supplement), p.C067-C067

2023

Volltextzugriff (PDF)

Abstract P3-07-21: Breast cancer subtype and survival in a population-based cohort of patients from California

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P3-P3-07-21

2015

Volltextzugriff (PDF)

A Pilot study of the Sharing Risk Information Tool (ShaRIT) for Families with Hereditary Breast and Ovarian Cancer Syndrome

Hereditary cancer in clinical practice, 2012-04, Vol.10 (1), p.4-4, Article 4

2012

Volltextzugriff (PDF)

1 – 25 von 306

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(220)
Mit Volltextzugriff
(263)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study

Clinical and biomarker predictors of side effects from tamoxifen

Communication of BRCA Results and Family Testing in 1,103 High-Risk Women

Comparison of Methods to Measure Low Serum Estradiol Levels in Postmenopausal Women

Eligibility criteria in private and public coverage policies for BRCA genetic testing and genetic counseling

Pharmacogenetic testing affects choice of therapy among women considering tamoxifen treatment

Family Communication of BRCA1/2 Results and Family Uptake of BRCA1/2 Testing in a Diverse Population of BRCA1/2 Carriers

Association of statin use and development and progression of hip osteoarthritis in elderly women

Classifying Variants of Undetermined Significance in BRCA2 with Protein Likelihood Ratios

Fecal Incontinence in Females Older Than Aged 40 Years: Who is at Risk?

Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers

Pre-counseling Education for Low Literacy Women at Risk of Hereditary Breast and Ovarian Cancer (HBOC): Patient Experiences Using the Cancer Risk Education Intervention Tool (CREdIT)

Characteristics and temporal trends in patient registries: focus on the life sciences industry, 1981-2012

Prevalence and characteristics of pancreatic cancer in families with BRCA1 and BRCA2 mutations

Endogenous Sex Hormones, Breast Cancer Risk, and Tamoxifen Response: An Ancillary Study in the NSABP Breast Cancer Prevention Trial (P-1)

Genetic counseling, cancer screening, breast cancer characteristics, and general health among a diverse population of BRCA genetic testers

NatHER: protocol for systematic evaluation of trends in survival among patients with HER2-positive advanced breast cancer

Update in Women’s Health

Differences in US healthcare coverage policies in BRCA testing and potential implications

C-reactive protein and ischemia in users and nonusers of β-blockers and statins: Data from the Heart and Soul Study

Pertuzumab and trastuzumab for HER2-amplified metastatic colorectal cancer: an updated report from MyPathway, a multicentre, open-label, phase 2a multiple basket study

Coronary Heart Disease in Women: Hormone Replacement Therapy

Abstract C067: Evaluation of data from a new mobile HPV vaccination program in South Carolina, U.S

Abstract P3-07-21: Breast cancer subtype and survival in a population-based cohort of patients from California

A Pilot study of the Sharing Risk Information Tool (ShaRIT) for Families with Hereditary Breast and Ovarian Cancer Syndrome

Suchergebnisse filtern